ATE435028T1 - Impfstoff gegen neisseria infektion - Google Patents

Impfstoff gegen neisseria infektion

Info

Publication number
ATE435028T1
ATE435028T1 AT00968062T AT00968062T ATE435028T1 AT E435028 T1 ATE435028 T1 AT E435028T1 AT 00968062 T AT00968062 T AT 00968062T AT 00968062 T AT00968062 T AT 00968062T AT E435028 T1 ATE435028 T1 AT E435028T1
Authority
AT
Austria
Prior art keywords
vaccine against
against neisseria
neisseria
neisseria infection
vaccine
Prior art date
Application number
AT00968062T
Other languages
English (en)
Inventor
Joyce S Plested
Michael P Jennings
Margaret Ann J Gidney
Andrew D Cox
James C Richards
E Richard Moxon
Original Assignee
Isis Innovation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26853671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE435028(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Isis Innovation filed Critical Isis Innovation
Application granted granted Critical
Publication of ATE435028T1 publication Critical patent/ATE435028T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1217—Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
AT00968062T 1999-09-30 2000-10-02 Impfstoff gegen neisseria infektion ATE435028T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15694099P 1999-09-30 1999-09-30
US19630500P 2000-04-12 2000-04-12
PCT/GB2000/003758 WO2001022994A2 (en) 1999-09-30 2000-10-02 Vaccines against neisseria infection

Publications (1)

Publication Number Publication Date
ATE435028T1 true ATE435028T1 (de) 2009-07-15

Family

ID=26853671

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00968062T ATE435028T1 (de) 1999-09-30 2000-10-02 Impfstoff gegen neisseria infektion

Country Status (8)

Country Link
US (8) US7585510B1 (de)
EP (3) EP2364726A3 (de)
AT (1) ATE435028T1 (de)
AU (1) AU782337B2 (de)
CA (1) CA2386025A1 (de)
DE (1) DE60042489D1 (de)
ES (1) ES2327895T3 (de)
WO (1) WO2001022994A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2364726A3 (de) * 1999-09-30 2011-11-09 Isis Innovation Limited Impfstoff gegen Neisseria-Infektion
RU2364418C2 (ru) * 2002-08-02 2009-08-20 ГлаксоСмитКлайн Байолоджикалз с.а. ВАКЦИННЫЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ЛИПОПОЛИСАХАРИДЫ ИММУНОТИПА L2 И/ИЛИ L3, ПРОИСХОДЯЩИЕ ИЗ ШТАММА NEISSERIA MENINGITIDIS IgtB-
CA2761924C (fr) 2009-05-14 2017-10-31 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2010134225A1 (ja) * 2009-05-20 2010-11-25 国立大学法人鳥取大学 部分糖鎖エピトープを用いた、病原性ナイセリア属細菌感染の検出方法およびそれら細菌に対するワクチン
EP2573100A1 (de) * 2011-09-23 2013-03-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Totalsynthese des Kern-Tetrasaccharids des Lipopolysaccharids von Neisseria meningitidis
WO2016007891A1 (en) * 2014-07-10 2016-01-14 University Of Iowa Research Foundation Vaccine for nontypeable haemophilus influenzae
CN110072872B (zh) * 2016-11-04 2024-01-16 环境、食品及农村国务部 预防由布鲁氏菌生物引起的感染的疫苗
US12005110B2 (en) 2019-02-14 2024-06-11 University Of Florida Research Foundation, Incorporated Honeybee commensal Snodgrassella alvi vaccine against pathogenic Neisseriaceae
CN111289642B (zh) * 2020-03-04 2021-03-02 苏州金纬标检测有限公司 液相色谱串联质谱定量检测纳米材料表面脂多糖的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CA1340506C (en) * 1987-11-24 1999-04-20 Nicholas H. Carbonetti Production of gonorrheal pi proteins and vaccines
NL9101359A (nl) * 1991-08-07 1993-03-01 Nederlanden Staat Nieuw saccharide-peptide-conjugaat, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk saccharide-peptide-conjugaat omvat.
NL9201716A (nl) 1992-10-02 1994-05-02 Nederlanden Staat Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.
CA2264970A1 (en) * 1998-03-10 1999-09-10 American Cyanamid Company Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria
US6531131B1 (en) * 1999-08-10 2003-03-11 The United States Of America As Represented By The Department Of Health And Human Services Conjugate vaccine for Neisseria meningitidis
EP2364726A3 (de) * 1999-09-30 2011-11-09 Isis Innovation Limited Impfstoff gegen Neisseria-Infektion
US7537766B2 (en) * 2004-08-30 2009-05-26 Wyeth Neisseria meningitidis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof

Also Published As

Publication number Publication date
US7825225B2 (en) 2010-11-02
WO2001022994A3 (en) 2001-10-11
US20110171234A1 (en) 2011-07-14
AU7802300A (en) 2001-04-30
US20100010211A1 (en) 2010-01-14
CA2386025A1 (en) 2001-04-05
US8148499B2 (en) 2012-04-03
US7910117B2 (en) 2011-03-22
ES2327895T3 (es) 2009-11-05
EP1220686B1 (de) 2009-07-01
AU782337B2 (en) 2005-07-21
US7923018B2 (en) 2011-04-12
US20120121646A1 (en) 2012-05-17
WO2001022994A2 (en) 2001-04-05
US7585510B1 (en) 2009-09-08
US20100010210A1 (en) 2010-01-14
EP2364726A2 (de) 2011-09-14
EP2110137A1 (de) 2009-10-21
US20140050731A1 (en) 2014-02-20
US20100015175A1 (en) 2010-01-21
EP2364726A3 (de) 2011-11-09
EP1220686A2 (de) 2002-07-10
US20100016560A1 (en) 2010-01-21
US8535688B2 (en) 2013-09-17
DE60042489D1 (de) 2009-08-13
US8173798B2 (en) 2012-05-08

Similar Documents

Publication Publication Date Title
DE122010000042I1 (de) Solubilisierung von capsulären Polysacchariden
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
NO20015073D0 (no) Vaksiner
CY2012030I2 (el) Πολυδυναμο εμβολιο προϊοντος συζευξης μηνιγγοκοκκικου πολυσακχαριδιου-πρωτεϊνης
DK1079857T3 (da) Meningitidis B/C-kombinationsvacciner
CY1107146T1 (el) Μεθοδοι για προληψη και θεραπεια ασθενειας alzheimer (ad)
CY1112229T1 (el) Αντισωματα κατευθυνομενα εναντι οξειδωμενης απολιποπρωτεϊνης β
WO2006065553A3 (en) Glycoconjugate vaccines containing peptidoglycan
ATE435028T1 (de) Impfstoff gegen neisseria infektion
DE60331412D1 (de) Hiv-vakzine und anwendungsverfahren
ATE269104T1 (de) Salmonella impfstoff, der keinen antikörper gegen flagellin oder gegen flagella induziert
HUP0000362A2 (hu) Madár-reovírusok új antigén osztálya
DE60336063D1 (de) Verfahren, zusammensetzung und kit für die antigenbindung von norwalk-ähnlichen viren
CY1114309T1 (el) Εμβολιο ροταϊου

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties